4.7 Article

Neoadjuvant therapy of metformin is associated with good tumor response after preoperative concurrent chemoradiotherapy for rectal cancer

Related references

Note: Only part of the references are listed.
Review Radiology, Nuclear Medicine & Medical Imaging

Essential. Items for Structured Reporting of Rectal. Cancer MRI: 2016 Consensus Recommendation from the Korean Society of Abdominal. Radiology

Seung Hyun Cho et al.

KOREAN JOURNAL OF RADIOLOGY (2017)

Article Oncology

Metformin enhances the response to radiotherapy in diabetic patients with rectal cancer

Bo Young Oh et al.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2016)

Article Gastroenterology & Hepatology

Defining response to radiotherapy in rectal cancer using magnetic resonance imaging and histopathological scales

Muhammed R. S. Siddiqui et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2016)

Review Oncology

Metformin: A Novel Biological Modifier of Tumor Response to Radiation Therapy

Marianne Koritzinsky

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2015)

Article Oncology

Metformin use and improved response to therapy in rectal cancer

Heath D. Skinner et al.

CANCER MEDICINE (2013)

Article Endocrinology & Metabolism

Metformin Associated With Lower Cancer Mortality in Type 2 Diabetes - ZODIAC-16

Gijs W. D. Landman et al.

DIABETES CARE (2010)

Article Radiology, Nuclear Medicine & Medical Imaging

Restaging of Rectal Cancer with MR Imaging after Concurrent Chemotherapy and Radiation Therapy

Dae Jung Kim et al.

RADIOGRAPHICS (2010)

Article Medicine, General & Internal

Chemotherapy with preoperative radiotherapy in rectal cancer

Jean-Francois Bosset et al.

NEW ENGLAND JOURNAL OF MEDICINE (2006)

Article Medicine, General & Internal

Preoperative versus postoperative chemoradiotherapy for rectal cancer

R Sauer et al.

NEW ENGLAND JOURNAL OF MEDICINE (2004)